bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study (Q42481800)

1 November 2017

bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study (English)

1 reference

1 November 2017

oral mucosa leukoplakia

1 reference

1 reference

Piattelli A

1

1 reference

1 November 2017

Fioroni M

series ordinal

2

1 reference

1 November 2017

Santinelli A

series ordinal

3

1 reference

1 November 2017

Rubini C

series ordinal

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

1 November 2017

1 reference

1 November 2017

35

1 reference

1 November 2017

3

1 reference

1 November 2017

314-320

1 reference

Retinoid actions and implications for prevention and therapy of oral cancer

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

All-trans retinoic acid induced gene expression and growth inhibition in head and neck cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Chemoprevention of oral carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Second cancers occurring after cancers of the mouth and pharynx: data from three population-based registries in Australia, Scotland and Slovenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Field cancerisation of the oral cavity: comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Progressive 13-cis-retinoic acid dosage in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Treatment of oral leukoplakia with beta-carotene

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Retinoids in cancer prevention and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Inhibition of experimental oral carcinogenesis by topical beta carotene

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Premalignant lesions: role of antioxidant vitamins and beta-carotene in risk reduction and prevention of malignant transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Remission of precancerous lesions in the oral cavity of tobacco chewers and maintenance of the protective effect of beta-carotene or vitamin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

bcl-2: role in epithelial differentiation and oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Apoptosis in normal epithelium, premalignant and malignant lesions of the oropharynx and oral cavity: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Apoptosis-associated markers in oral lichen planus.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2898%2900095-5

7 January 2021

10.1016/S1368-8375(98)00095-5

Identifiers

DOI

1 reference

1 November 2017

1 reference